[HTML][HTML] Nanotechnology-based drug delivery for central nervous system disorders

TT Nguyen, TTD Nguyen, TK Vo, MK Nguyen… - Biomedicine & …, 2021 - Elsevier
Drug delivery to central nervous system (CNS) diseases is very challenging since the
presence of the innate blood–brain barrier (BBB) and the blood-cerebrospinal fluid barrier …

Advanced nanomedicines for the treatment of inflammatory diseases

R Brusini, M Varna, P Couvreur - Advanced drug delivery reviews, 2020 - Elsevier
Inflammation, a common feature of many diseases, is an essential immune response that
enables survival and maintains tissue homeostasis. However, in some conditions, the …

[HTML][HTML] Recent advances in nanomedicines for the treatment of ischemic stroke

C Li, T Sun, C Jiang - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Ischemic stroke is a cerebrovascular disease normally caused by interrupted blood supply to
the brain. Ischemia would initiate the cascade reaction consisted of multiple biochemical …

Blood-brain barrier protection as a therapeutic strategy for acute ischemic stroke

AE Sifat, B Vaidya, TJ Abbruscato - The AAPS Journal, 2017 - Springer
The blood-brain barrier (BBB) is a vital component of the neurovascular unit (NVU)
containing tight junctional (TJ) proteins and different ion and nutrient transporters which …

Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model

PM Saffari, S Alijanpour, N Takzaree, M Sahebgharani… - Life sciences, 2020 - Elsevier
Alzheimer's disease (AD) is closely associated with neuroinflammation development in the
brain. Co-delivery of metformin (MET) with phosphatidylserine liposomes neuroprotectant …

Nanoparticles: A Hope for the Treatment of Inflammation in CNS

FD Zhu, YJ Hu, L Yu, XG Zhou, JM Wu… - Frontiers in …, 2021 - frontiersin.org
Neuroinflammation, an inflammatory response within the central nervous system (CNS), is a
main hallmark of common neurodegenerative diseases, including Alzheimer's disease (AD) …

Progresses and prospects of neuroprotective agents-loaded nanoparticles and biomimetic material in ischemic stroke

J Chen, J Jin, K Li, L Shi, X Wen, F Fang - Frontiers in Cellular …, 2022 - frontiersin.org
Ischemic stroke remains the leading cause of death and disability, while the main
mechanisms of dominant neurological damage in stroke contain excitotoxicity, oxidative …

Therapeutic peptides to treat myocardial ischemia-reperfusion injury

C Fernandez Rico, K Konate, E Josse… - Frontiers in …, 2022 - frontiersin.org
Cardiovascular diseases (CVD) including acute myocardial infarction (AMI) rank first in
worldwide mortality and according to the World Health Organization (WHO), they will stay at …

[HTML][HTML] Liposomes for drug delivery in stroke

GE Bruch, LF Fernandes, BLT Bassi, MTR Alves… - Brain research …, 2019 - Elsevier
Stroke is one of the leading causes of mortality and morbidity worldwide. Due to its poor
prognosis, there is a major negative impact on the patients and their family's life quality …

Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review

W Chen, L Jiang, Y Hu, G Fang, B Yang, J Li… - Journal of Controlled …, 2021 - Elsevier
Owing to its intricate pathophysiology, cerebral stroke is a serious medical condition caused
by interruption or obstruction of blood supply (blockage of vasculature) to the brain tissues …